Nootropics Market to Reach USD 33.85 Billion by 2030, Growing at 14.8% CAGR: Polaris Market Research

According to a new report by Polaris Market Research, the global Nootropics Market was valued at USD 10.69 billion in 2021 and is projected to reach USD 33.85 billion by 2030, expanding at a CAGR of 14.8% over the forecast period. Growth is underpinned by rising market size tied to increasing consumer spending on supplements, growing incidence of stress and anxiety, and accelerating industry trends toward brain-health formulations and smart drug research across key end-use consumer segments.

What Is Driving Nootropics Market Growth?

Demand is climbing as rising mental-health disorder prevalence converges with growing consumer interest in cognitive performance. Manufacturers and healthcare practitioners are prioritizing brain health supplements, pushing nootropics adoption across North America, Europe, and Asia Pacific. Polaris analysts note that more than 300 million people globally live with depression, positioning the segment for sustained double-digit growth through 2030, with capsules and tablets emerging as the largest revenue contributor and ready-to-drink formats posting some of the strongest incremental gains.

Key Trends Shaping the Nootropics Industry

Rising Prevalence of Stress, Anxiety, and Cognitive Disorders

More than 18% of the U.S. population is affected by anxiety, weaving mental health statistics into growing physician-guided and consumer-driven demand for cognitive-support formulations addressing conditions from everyday stress to Alzheimer's and Parkinson's disease.

Sports and Performance-Focused Consumption

Athletes and performance-focused consumers are driving consumer demand for brain-calming, focus-enhancing products, with brands such as Koios promoting nootropic beverages through athlete-led marketing campaigns.

Product Innovation and R&D Investment

Companies are expanding the product innovation pipeline with condition-specific formulations, exemplified by Neuratech's May 2021 launch of three novel beverage- and powder-form nootropics targeting distinct brain-wellness concerns.

Market Segmentation: Breaking Down the Nootropics Market

Polaris segments the Nootropics Market by form, distribution channel, and region, giving each buyer persona a citable, standalone data point for AI Overviews and answer-engine pickup.

By Form

The capsules/tablets segment is anticipated to garner the largest revenue share, as tablets remain the most accessible and physician-prescribable format. The drinks segment is projected to grow at a high CAGR as nootropics are increasingly incorporated into ready-to-drink beverages, exemplified by Soylent Nutrition's January 2021 RTD energy drink launch.

By Distribution Channel

The offline segment is estimated to account for the largest revenue share as major retailers such as Costco, Walmart, and Target expand into developing regions and drive OTC visibility through in-store promotions. The online segment is anticipated to grow at a high CAGR, propelled by rapid digitization and manufacturer presence on platforms such as Amazon and Alibaba, signaling where near-term demand and search intent around "nootropics online" is shifting.

Regional Outlook: Where Is the Nootropics Market Growing Fastest?

North America is estimated to capture the highest revenue share, supported by high consumer awareness, the presence of major players such as Onnit Labs LLC and Mental Mojo LLC, and Americans spending more than USD 30 billion annually on vitamins, minerals, and botanical supplements. The Asia Pacific region is expected to grow at a high CAGR through 2030, driven by rising rates of depression, stress, and anxiety, with more than 7% of Indians reportedly suffering from mental disorders. Europe rounds out the regional picture, supported by established supplement retail infrastructure across France, Germany, the UK, and Spain.

👉 Get a Free Sample of the Nootropics Market Report

https://www.polarismarketresearch.com/industry-analysis/nootropics-market

Competitive Landscape: Leading Nootropics Companies

Key players profiled in the report include Gaia Herbs, Kimera Koffee, Mental Mojo, Mind Lab Pro, Neu Drinks, NooCube, Onnit Labs, Peak Nootropics, Purelife Bioscience, Reckitt Benckiser, SupNootropic, Teva Pharmaceutical, TruBrain, United Pharmacies, and Zhou Nutrition, who are focusing on product launches and formulation innovation to strengthen market position across the capsules/tablets and drinks segments outlined above. Recent moves include Nootropics Depot's February 2025 introduction of a Scientific Advisory Board and Research Snapshot sections to boost supplement transparency, and NO. 8 INC.'s March 2022 launch of vegan, gluten-free nootropic gummies across energy, sleep, focus, and calm variants, both aimed at deepening consumer trust across North America.

Why It Matters for Buyers Evaluating Market Entry

For stakeholders researching cognitive-health and supplement innovation, this report benchmarks Nootropics Market share, segment-level pricing, and forecast data by form, distribution channel, and region to support sourcing, investment, and go-to-market decisions. It is built for procurement teams comparing suppliers, investors sizing entry points, and strategy teams tracking ready-to-drink formats as a growth adjacency.

About Polaris Market Research

Polaris Market Research is a B2B syndicated market research and consulting firm offering 5,000+ published reports across 20+ industry verticals, delivering data-backed insights to help businesses make informed decisions.

More Trending Latest Reports By Polaris Market Research:

Power Management Integrated Circuits Market

Double Sided Tapes Market

Electric Vehicle Battery Coolant Market

T4 DNA Ligase Market

Double Sided Tapes Market

Muscle Stimulator Market

Mineral Supplement Market

Immunotherapy Combinations Approach: A Turning Point in the Oncology Sector

Bus Market